Current Value of Holding

$33.6 Million

Shares

36.5 Million

% of Portfolio

0.31%

Average Buy Price

$10.4

Avg closing price
Price range

29 Cathie Wood Pacific Biosciences of California Trades

Cathie Wood's position in Pacific Biosciences of California is currently worth $33.6 Million. That's 0.31% of their equity portfolio (48th largest holding). The investor owns 12.16% of the outstanding Pacific Biosciences of California stock. The first Pacific Biosciences of California trade was made in Q3 2017. Since then Cathie Wood bought shares 22 more times and sold shares on ten occasions. The investor's estimated purchase price is $381 Million, resulting in a loss of 91%.

Avg closing price
Price range
Increased shares by 1.2% (+434 Thousand shares) Q1 2025
Avg closing price $1.55
Price range $1.14 - $2.10
Increased shares by 7.9% (+2.64 Million shares) Q4 2024
Avg closing price $1.95
Price range $1.55 - $2.65
Increased shares by 0.6% (+194 Thousand shares) Q3 2024
Avg closing price $1.63
Price range $1.20 - $2.18
Sold 0.2% shares (-77.7 Thousand shares) Q2 2024
Avg closing price $2.02
Price range $1.35 - $3.65
Sold 3.5% shares (-1.21 Million shares) Q1 2024
Avg closing price $5.86
Price range $3.52 - $9.59
Increased shares by 15.7% (+4.68 Million shares) Q4 2023
Avg closing price $8.18
Price range $5.97 - $10.36
Increased shares by 12.0% (+3.19 Million shares) Q3 2023
Avg closing price $11.43
Price range $8.23 - $13.93
Sold 4.0% shares (-1.12 Million shares) Q2 2023
Avg closing price $12.15
Price range $9.97 - $14.05
Increased shares by 8.0% (+2.06 Million shares) Q1 2023
Avg closing price $9.94
Price range $7.94 - $12.02
Sold 10.5% shares (-3 Million shares) Q4 2022
Avg closing price $8.62
Price range $5.67 - $11.20
Increased shares by 2.3% (+647 Thousand shares) Q3 2022
Avg closing price $5.74
Price range $3.92 - $8.79
Increased shares by 2.9% (+786 Thousand shares) Q2 2022
Avg closing price $6.08
Price range $4.02 - $10.43
Increased shares by 3.3% (+876 Thousand shares) Q1 2022
Avg closing price $11.51
Price range $8.43 - $20.90
Increased shares by 16.1% (+3.66 Million shares) Q4 2021
Avg closing price $24.13
Price range $19.26 - $30.08
Increased shares by 10.9% (+2.24 Million shares) Q3 2021
Avg closing price $29.63
Price range $24.86 - $35.02
Sold 3.8% shares (-820 Thousand shares) Q2 2021
Avg closing price $29.09
Price range $22.30 - $36.02
Sold 25.3% shares (-7.2 Million shares) Q1 2021
Avg closing price $35.00
Price range $26.38 - $51.15
Increased shares by 43.6% (+8.66 Million shares) Q4 2020
Avg closing price $16.99
Price range $10.50 - $28.50
Increased shares by 141.1% (+11.6 Million shares) Q3 2020
Avg closing price $5.76
Price range $3.60 - $9.87
Increased shares by 96.3% (+4.04 Million shares) Q2 2020
Avg closing price $3.40
Price range $2.65 - $4.03

News about Pacific Biosciences of California Inc and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!